Sanstar Q1 FY27 net profit at Rs 9.21 Cr vs loss last year, revenue up 21%

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

SANSTAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹112.80

prior close

₹110.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-1.7% vs market

Other Agricultural Products peers, median of 54sector+0.0%-1.6% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.6 pts less than its Other Agricultural Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

-1.5

15m

-2.1

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+0.1-1.7+0.0-1.6

Next day

-3.8+0.2-4.0+1.0-4.8

-5.2+0.6-5.8+0.7-5.9

-5.2-0.0-5.1-0.0-5.1

-6.4+0.5-6.9+0.5-6.9

-6.4+0.8-7.1+1.2-7.6

-3.6+0.6-4.2+0.9-4.5

15d

-2.0+1.3-3.3+0.1-2.1

-1.1-1.4+0.3+0.4-1.5

-13.3-0.6-12.7+3.1-16.3

—————

UpDownMarket · Nifty Microcap 250Sector · Other Agricultural Products peers, median of 54Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 revenue rose to Rs 206.16 Cr vs Rs 169.66 Cr YoY, up about 21%. Net profit swung to Rs 9.21 Cr from a loss of Rs 0.33 Cr last year. Total income was Rs 208.93 Cr. The company completed a Rs 198.27 Cr preferential issue to Corn Products Development Inc and acquired 30% in Spark Ingredients. Board approved reappointment of MD and two JMDs for 5 years and appointed a nominee director and an independent director.

Likely market impact

Strong YoY recovery with revenue and profit growth, backed by a Rs 198 Cr fundraise. Board continuity maintained via MD reappointments.